Equate Effervescent Cold Relief Tablet, Effervescent
NDC Package 49035-768-67

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Equate Effervescent Cold Relief (aspirin, chlorpheniramine maleate, phenylephrine bitartrate) tablets is ■ do not use more than directed (see overdose warning)■ adults and children 12 years and over: take 2 tablets completely dissolved in 4 oz of water every 4-6 hours.■ do not take more than 8 tablets in 24 hours■ children under 12 years: ask a doctor. This formulation utilizes a tablet, effervescent delivery system. Marketed by Walmart, this product is identified by NDC 49035-768 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
49035-768-67
Package Description
24 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
Product Code
49035-768
11-Digit Billing Format
49035076867
RxNorm Crosswalk
  • RxCUI: 1536840 - aspirin 325 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
  • RxCUI: 1536840 - ASA 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet

Clinical Specifications

Proprietary Name
Equate Effervescent Cold Relief
Non-Proprietary Name
Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate
Substance Name
Aspirin; Chlorpheniramine Maleate; Phenylephrine Bitartrate
Dosage Form
Tablet, Effervescent - A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
■ do not use more than directed (see overdose warning)■ adults and children 12 years and over: take 2 tablets completely dissolved in 4 oz of water every 4-6 hours.■ do not take more than 8 tablets in 24 hours■ children under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Walmart
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-02-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49035-768-67 identifies a specific commercial package of 24 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Equate Effervescent Cold Relief, a human over the counter drug labeled by Walmart. This tablet, effervescent is formulated for oral use and contains aspirin; chlorpheniramine maleate; phenylephrine bitartrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walmart on November 02, 2017. The current certification is valid through December 31, 2026.

How is this Walmart product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49035076867. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49035-768-67
11-Digit CMS (5-4-2)
49035-0768-67

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.